Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
199
-
Total 13F shares, excl. options
-
120M
-
Shares change
-
+3.69M
-
Total reported value, excl. options
-
$3.34B
-
Value change
-
+$82.8M
-
Put/Call ratio
-
1.55
-
Number of buys
-
106
-
Number of sells
-
-97
-
Price
-
$27.89
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q2 2017
261 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q2 2017.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 199 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 120M shares
of 170M outstanding shares and own 70.42% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (25.8M shares), FMR LLC (18.3M shares), VANGUARD GROUP INC (7.6M shares), BlackRock Inc. (5.59M shares), OppenheimerFunds, Inc. (5.07M shares), STATE STREET CORP (3.75M shares), JANUS HENDERSON GROUP PLC (3.66M shares), FRANKLIN RESOURCES INC (3.57M shares), PRICE T ROWE ASSOCIATES INC /MD/ (3.46M shares), and WADDELL & REED FINANCIAL INC (3.14M shares).
This table shows the top 199 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.